Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial

Overview of attention for article published in Frontiers in immunology, April 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 12 Mendeley

So far, Altmetric has seen 1 X post from an account with 33,232 followers.

New Research: Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial: Background Programmed cell death-ligand 1 (PD-L1)… https://t.co/vNk

11 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.